Inhibition of carboxylesterases by benzil (diphenylethane-1,2-dione) and heterocyclic analogues is dependent upon the aromaticity of the ring and the flexibility of the dione moiety.
暂无分享,去创建一个
M. Zeller | A. D. Hunter | M. Wierdl | P. Potter | M. Danks | R. M. Wadkins | C. Edwards | K. Yoon | G. Crundwell | Vanessa Stacy | J. Hyatt
[1] P. Beroza,et al. Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases. , 2005, Journal of medicinal chemistry.
[2] P. Beroza,et al. Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activity. , 2004, Molecular pharmacology.
[3] P. Beroza,et al. Chemoproteomics as a basis for post-genomic drug discovery. , 2002, Drug discovery today.
[4] M. Wierdl,et al. Structural constraints affect the metabolism of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) by carboxylesterases. , 2001, Molecular pharmacology.
[5] C. Morton,et al. Comparison of Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, Spodoptera frugiperda, and COS7 cells for recombinant gene expression , 2000, Molecular biotechnology.
[6] C. Morton,et al. Proficient metabolism of irinotecan by a human intestinal carboxylesterase. , 2000, Cancer research.
[7] M. Wierdl,et al. Activation of CPT-11 in mice: identification and analysis of a highly effective plasma esterase. , 2000, Cancer research.
[8] Steven L. Dixon,et al. Investigation of classification methods for the prediction of activity in diverse chemical libraries , 1999, J. Comput. Aided Mol. Des..
[9] D. V. Von Hoff,et al. Water soluble 20(S)-glycinate esters of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenografts. , 1999, Cancer research.
[10] P. Houghton,et al. Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] C. Morton,et al. The anticancer prodrug CPT-11 is a potent inhibitor of acetylcholinesterase but is rapidly catalyzed to SN-38 by butyrylcholinesterase. , 1999, Cancer research.
[12] Steven L. Dixon,et al. Bioactive Diversity and Screening Library Selection via Affinity Fingerprinting , 1998, J. Chem. Inf. Comput. Sci..
[13] M. Wierdl,et al. Cellular localization domains of a rabbit and a human carboxylesterase: influence on irinotecan (CPT-11) metabolism by the rabbit enzyme. , 1998, Cancer research.
[14] G. Vassal,et al. Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] C. Morton,et al. Isolation and partial characterization of a cDNA encoding a rabbit liver carboxylesterase that activates the prodrug irinotecan (CPT-11). , 1998, Cancer research.
[16] Louis J. Farrugia,et al. ORTEP-3 for Windows - a version of ORTEP-III with a Graphical User Interface (GUI) , 1997 .
[17] J Zhang,et al. Purification and Cloning of a Broad Substrate Specificity Human Liver Carboxylesterase That Catalyzes the Hydrolysis of Cocaine and Heroin* , 1997, The Journal of Biological Chemistry.
[18] Pinghua Ge,et al. Poly(2-thienyl)borates: An Investigation into the Coordination of Thiophene and Its Derivatives. , 1996, Inorganic chemistry.
[19] L. Rivory,et al. IRINOTECAN (CPT‐11): A BRIEF OVERVIEW , 1996, Clinical and experimental pharmacology & physiology.
[20] J R Cashman,et al. Pharmacokinetics and molecular detoxication. , 1996, Environmental health perspectives.
[21] W. Bosron,et al. Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine. , 1994, Biochemical pharmacology.
[22] T. Satoh,et al. Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1- piperidino]carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase. , 1994, Biological & pharmaceutical bulletin.
[23] A. Székács,et al. Hydrolysis of Carbonates, Thiocarbonates, Carbamates, and Carboxylic Esters of α-Naphthol, β-Naphthol, and p-Nitrophenol by Human, Rat, and Mouse Liver Carboxylesterases , 1993, Pharmaceutical Research.
[24] James J. P. Stewart,et al. MOPAC: A semiempirical molecular orbital program , 1990, J. Comput. Aided Mol. Des..
[25] J. Stewart. Optimization of parameters for semiempirical methods I. Method , 1989 .
[26] I. Silman,et al. Microtiter assay for acetylcholinesterase. , 1987, Analytical biochemistry.
[27] H. Flack,et al. On enantiomorph‐polarity estimation , 1983 .
[28] Michael J. S. Dewar,et al. Ground states of conjugated molecules. XI. Improved treatment of hydrocarbons , 1969 .
[29] K. Courtney,et al. A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.
[30] M. Weiss,et al. The catalytic oxidation of benzoin to benzil. , 1948, Journal of the American Chemical Society.
[31] P. Potter,et al. Enzyme-prodrug systems: carboxylesterase/CPT-11. , 2004, Methods in molecular medicine.
[32] P. Potter,et al. Enzyme-Prodrug Systems , 2004 .
[33] M Hosokawa,et al. The mammalian carboxylesterases: from molecules to functions. , 1998, Annual review of pharmacology and toxicology.
[34] E. Cvitkovic,et al. Characterisation and clinical management of CPT-11 (irinotecan)-induced adverse events: the European perspective. , 1996, European journal of cancer.
[35] A. Székács,et al. Hydrolysis of carbonates, thiocarbonates, carbamates, and carboxylic esters of alpha-naphthol, beta-naphthol, and p-nitrophenol by human, rat, and mouse liver carboxylesterases. , 1993, Pharmaceutical research.
[36] M. Dewar,et al. Aromatic energies of some heteroaromatic molecules , 1989 .
[37] A. Gordon,et al. The Chemist's Companion: A Handbook of Practical Data, Techniques, and References , 1972 .
[38] N. Trinajstic,et al. Ground states of conjugated molecules—XIV: Redox potentials of quinones , 1965 .
[39] John Leyden. Webb,et al. Enzyme and metabolic inhibitors , 1963 .